ANXA6 and neoplasm: Leca et al. demonstrated that EVs derived from cancer-associated fibroblasts (CAFs) undergoing non-physiologic culture conditions were enriched in ANXA6 and stimulated tumor growth and aggressiveness probably by activating the ANXA6/LRP1/TSP1 complex [42].